Join to View Full Profile
504 E 63rd StAp 6oNew York, NY 10065
Phone+1 929-262-9067
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rodrigo Munhoz, MD is a hematologist in New York, New York.
Clinical Trials
- Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2019 Sep 05
Publications & Presentations
PubMed
- Challenges of Treating Merkel Cell Carcinoma in Brazil.Matheus de Melo Lobo, João Pedreira Duprat Neto, Milton José de Barros E Silva, Rodrigo Ramella Munhoz, Andreia Cristina de Melo
Journal of Surgical Oncology. 2025-07-01 - Guideline Utilization in Oncology: Addressing Barriers and Facilitators in Latin America and the Caribbean.Yanin Chavarri-Guerra, Luis Corrales, James D Morgante, Henry Gomez, Alba Kihn-Alarcón
JCO Global Oncology. 2025-06-01 - Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group.Douglas Dias E Silva, Bruna Bianca Lopes David, Veridiana Pires de Camargo, Renee Zon Filipi, María Lucila González Donna
JCO Global Oncology. 2025-01-01
Press Mentions
Nivolumab Promising for Treatment of Advanced Cutaneous SCCOctober 26th, 2022- Promising Immunotherapy Drug May Soon Become Standard Treatment for Skin CancerOctober 26th, 2022
- Nearly Half of Parents Say They Have Leftover Prescription Medications at HomeOctober 24th, 2022
- Join now to see all
